Emergency physicians first to safely treat vaccine-induced blood clot with heparin alternative

Human mesenchymal stem cells show promise in treating chronic lung infections
4 May 2021
Do people aged 105 and over live longer because they have more efficient DNA repair?
4 May 2021

Emergency physicians first to safely treat vaccine-induced blood clot with heparin alternative

A new case report, detailed in Annals of Emergency Medicine, is the first known case of a patient with VITT (vaccine-induced thrombotic thrombocytopenia) treated with a heparin alternative following the Centers for Disease Control and Prevention (CDC) guidance.

Comments are closed.